SCHEMBL6575558

SCHEMBL6575558

O=CC1CC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12253468 0.94
SCHEMBL7294984 0.88
SCHEMBL14430964 0.84
SCHEMBL7358884 0.78
SCHEMBL7285546 0.78 LMNA (0.32)
SCHEMBL20273025 0.78 LMNA (0.32)
SCHEMBL27872081 0.74 TRPA1 (0.43)
SCHEMBL28840588 0.74
SCHEMBL17128813 0.74
SCHEMBL6573373 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110036009-A Substituted pyrrolidines and their use in the treatment of cystic fibrosis 艾伯维公司 2019-07-19 CN disclosed
CN-105531268-A Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis GALAPAGOS NV 2016-04-27 CN disclosed
EP-2497475-A1 Treatment of laminitis with platelet aggregation inhibitors Dussler, Sabine (DE) 2012-09-12 EP disclosed
CN-1192019-C Cyclic amine derivatives SANKYO CO (JP) 2005-03-09 CN disclosed
EP-0934928-B1 CYCLIC AMINE DERIVATIVES SANKYO CO (JP) 2004-10-13 EP disclosed
CN-1107502-C Preparation method for medicinal composition containing hydrogenated pyridine derivative as active components SANKYO CO (JP) 2003-05-07 CN disclosed
US-6087379-A AN ANTICOAGULANT FOR THE TREATMENT AND PREVENTION OF DISEASES AS EMBOLISM, THROMBOSIS OR ARTERIOSCLEROSIS SANKYO COMPANY, LIMITED (JP) 2000-07-11 US disclosed
EP-0934928-A1 CYCLIC AMINE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1999-08-11 EP disclosed
CN-1217186-A Preparation method for medicinal composition containing hydrogenated pyridine derivative as active components SANKYO CO (JP) 1999-05-26 CN disclosed
CN-1041730-C Process for preparing hydrogenated pyridine derivatives SANKYO CO (JP) 1999-01-20 CN disclosed
CN-1091288-A The oxytocin antagonist OTSUKA PHARMA CO LTD (JP) 1994-08-31 CN disclosed
EP-0602209-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-06-22 EP disclosed
EP-0382185-B1 Carbostyril derivatives OTSUKA PHARMA CO LTD (JP) 1994-06-15 EP disclosed
US-5288726-A Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation UBE INDUSTRIES LIMITED (JP) 1994-02-22 US disclosed
WO-1994001113-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1994-01-20 WO disclosed
CN-1074446-A Hydroxypyridine Derivatives SANKYO CO (JP) 1993-07-21 CN disclosed
US-5225402-A Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-07-06 US disclosed
EP-0542411-A2 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation Sankyo Company Limited (JP) 1993-05-19 EP disclosed
CN-1046529-A Carbostyril derivative OTSUKA PHARMA CO LTD (JP) 1990-10-31 CN disclosed
EP-0382185-A2 Carbostyril derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-08-16 EP disclosed